Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Detailed Status

Completed2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Trials by Status

completed267%

not_yet_recruiting133%

Recent Activity

0 active trials

Showing 3 of 3

not_yet_recruiting

Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

NCT03127111

completed

Gene Polymorphisms of Corticosteroid-induced Ocular Hypertension

NCT03250819

completed

Predictive Genetic Risk Assessment Trial

NCT00782366

Clinical Trials (3)

Showing 3 of 3 trials

NCT03127111

Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

Not Yet Recruiting

NCT03250819

Gene Polymorphisms of Corticosteroid-induced Ocular Hypertension

Completed

NCT00782366

Predictive Genetic Risk Assessment Trial

Completed

All 3 trials loaded

Drug Details

Intervention Type: GENETIC
Total Trials: 3